We are live on
!
Find out more
EP
Eversept Partners Portfolio holdings
AUM
$1.93B
Turnover
41.06%
1-Year Est. Return
160.8%
This Fund
S&P 500
This Quarter
Est. Return
+4.31%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.43B
AUM Growth
+$292M
(+26%)
Cap. Flow
+$65.8M
Cap. Flow
% of AUM
4.59%
Top 10 Holdings %
Top 10 Hldgs %
64.89%
Holding
82
New
14
Increased
33
Reduced
12
Closed
20
Avg Time Held Equity + Options
1.2
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
0.8
years
Avg Time Held Equity only
1.3
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Community Health Systems
CYH
|
+$37.3M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
+$35M |
| 3 |
Amarin Corp
AMRN
|
+$19.9M |
| 4 |
Amedisys
AMED
|
+$19.4M |
| 5 |
Teva Pharmaceutical Industries Limited
TEVA
|
+$14.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sanofi
SNY
|
+$77.7M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$27.1M |
| 3 |
Envista
NVST
|
+$21.6M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$17.9M |
| 5 |
Haleon
HLN
|
+$15.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 76.06% |
| 2 | Miscellaneous | 22.43% |
| 3 | Financials | 0.95% |
| 4 | Communication Services | 0.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Sonida Senior Living
SNDA
$1.69B
| – | – |
-11,791
| Closed | -$147K | – |
|
|
77
Sanofi
SNY
$96.3B
| – | – |
-1,603,348
| Closed | -$77.7M | – |
|
|
78
CALL
Teva Pharmaceutical Industries Limited
TEVA
$47.9B
| – | – |
-272,900
| Closed | -$2.49M | – |
|
|
79
CALL
State Street SPDR S&P Biotech ETF
XBI
$9.53B
| – | – |
-90,000
| Closed | -$7.47M | – |
|
|
80
State Street SPDR S&P Biotech ETF
XBI
$9.53B
| – | – |
-216,087
| Closed | -$17.9M | – |
|
81
CALL
DELISTED
CATALENT, INC.
CTLT
| – | – |
-2,000
| Closed | -$90K | – |
|
|
ISEE
82
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-350,747
| Closed | -$7.51M | – |
|
Similar funds
SWM
RIA
SI
SG
DCP
SI
MFM
FWP
Eversept Partners's Q1 2023 Portfolio in Review
As of Q1 2023, Eversept Partners held 82 positions worth $1.43B, up 26% from $1.14B the previous quarter. Its ten largest holdings account for 65% of the portfolio.
Eversept Partners deployed $65.8M of net new capital in Q1 2023, opening 14 new positions and adding to 33 existing holdings. Its largest new stake was Amedisys: 224,263 shares worth $16.5M.
By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 90% a quarter earlier, followed by Miscellaneous and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $27.1M trimmed.
- Eversept Partners's largest Q1 2023 buy was Amedisys: 224,263 shares worth $16.5M.
- Eversept Partners added most to Community Health Systems in Q1 2023, an estimated $37.3M increase.
- Eversept Partners's biggest Q1 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $27.1M.
- Eversept Partners fully exited Sanofi in Q1 2023, selling an estimated $77.7M.
- Eversept Partners's ten largest holdings make up 65% of its $1.43B portfolio in Q1 2023.
- Eversept Partners opened 14 new positions and closed 20 in Q1 2023.
- Eversept Partners's portfolio value rose 26% quarter-over-quarter to $1.43B.
Based on Eversept Partners's 13F filing for Q1 2023, filed 15 May 2023.